WINTON GROUP Ltd Invests $1.16 Million in Alignment Healthcare, Inc. $ALHC

WINTON GROUP Ltd bought a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) in the 2nd quarter, HoldingsChannel reports. The institutional investor bought 48,900 shares of the company’s stock, valued at approximately $1,164,000.

Other institutional investors have also added to or reduced their stakes in the company. Bank of America Corp DE raised its holdings in Alignment Healthcare by 156.5% in the 1st quarter. Bank of America Corp DE now owns 3,215,667 shares of the company’s stock valued at $56,660,000 after acquiring an additional 1,961,778 shares in the last quarter. 1492 Capital Management LLC grew its holdings in shares of Alignment Healthcare by 61.8% during the 4th quarter. 1492 Capital Management LLC now owns 324,865 shares of the company’s stock worth $6,416,000 after purchasing an additional 124,143 shares in the last quarter. William Blair Investment Management LLC grew its holdings in shares of Alignment Healthcare by 8.7% during the 4th quarter. William Blair Investment Management LLC now owns 2,305,255 shares of the company’s stock worth $45,529,000 after purchasing an additional 185,303 shares in the last quarter. Simplify Asset Management Inc. increased its position in shares of Alignment Healthcare by 92.0% during the fourth quarter. Simplify Asset Management Inc. now owns 262,880 shares of the company’s stock valued at $5,192,000 after purchasing an additional 125,946 shares during the period. Finally, Investment House LLC acquired a new position in shares of Alignment Healthcare in the fourth quarter valued at $1,665,000. 86.19% of the stock is owned by institutional investors and hedge funds.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $12.61 on Monday. Alignment Healthcare, Inc. has a 1 year low of $12.39 and a 1 year high of $25.12. The firm has a 50 day moving average of $16.17 and a 200-day moving average of $18.02. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 1.22. The stock has a market capitalization of $2.62 billion, a P/E ratio of 66.37 and a beta of 1.11.

Alignment Healthcare (NASDAQ:ALHC) last released its quarterly earnings results on Thursday, July 30th. The company reported $0.17 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.04. Alignment Healthcare had a return on equity of 20.02% and a net margin of 0.89%.The business had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the prior year, the company earned $0.07 EPS. Alignment Healthcare’s revenue for the quarter was up 31.6% on a year-over-year basis. As a group, sell-side analysts anticipate that Alignment Healthcare, Inc. will post 0.17 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ALHC has been the topic of a number of recent research reports. Raymond James Financial downgraded shares of Alignment Healthcare from a “strong-buy” rating to an “outperform” rating and decreased their price target for the stock from $22.00 to $19.00 in a research note on Monday, August 3rd. KeyCorp reiterated an “overweight” rating on shares of Alignment Healthcare in a research report on Wednesday, June 10th. Weiss Ratings reissued a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. UBS Group reissued a “neutral” rating on shares of Alignment Healthcare in a research report on Wednesday, July 8th. Finally, JPMorgan Chase & Co. cut their price target on shares of Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating for the company in a research note on Tuesday, August 4th. Seven analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $23.60.

Insider Buying and Selling at Alignment Healthcare

In other news, President Dawn Maroney sold 122,707 shares of the firm’s stock in a transaction on Friday, September 11th. The stock was sold at an average price of $12.68, for a total value of $1,555,924.76. Following the completion of the sale, the president directly owned 794,606 shares in the company, valued at approximately $10,075,604.08. This trade represents a 13.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, EVP Joseph S. Konowiecki sold 25,000 shares of Alignment Healthcare stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the transaction, the executive vice president directly owned 1,103,816 shares of the company’s stock, valued at $26,491,584. This represents a 2.21% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 1,326,577 shares of company stock worth $19,907,564. 5.20% of the stock is currently owned by insiders.

Trending Headlines about Alignment Healthcare

Here are the key news stories impacting Alignment Healthcare this week:

• Positive Sentiment: CEO John Kao’s sales were conducted under a pre-arranged Rule 10b5-1 plan and were intended to cover tax-withholding obligations tied to vested equity awards, reducing the likelihood that the transactions reflect a negative view of Alignment Healthcare’s business prospects. SEC Form 4 filing
• Neutral Sentiment: Alignment Health’s annual survey reported worsening challenges for seniors related to aging in place, support gaps and medical debt. The announcement highlights issues relevant to the company’s target market but does not provide a direct change to revenue, enrollment or earnings expectations. Alignment Health senior survey
• Neutral Sentiment: Reported short interest was zero shares, with a zero-day short-interest ratio. Because the figures show no measurable short position, they provide little evidence of either bearish positioning or potential short-covering support.
• Negative Sentiment: CEO John Kao sold a combined 557,870 shares across September 10–11, worth approximately $7.1 million, reducing his reported ownership. President Dawn Maroney also sold 122,707 shares for about $1.6 million. Although the transactions were tied to tax obligations, their size and timing can weigh on sentiment and may be contributing to the stock’s decline. SEC Form 4 filing
• Negative Sentiment: Kaplan Fox announced an investigation into Alignment Healthcare for possible securities-law violations. The announcement does not establish wrongdoing, but it introduces legal and reputational uncertainty that can pressure the stock. Kaplan Fox investigation announcement

Alignment Healthcare Profile

Alignment Healthcare, Inc is a technology-enabled healthcare company that provides Medicare Advantage health plans and care-management services for older adults. Through its Alignment Health Plan subsidiary, the company offers insurance coverage designed for Medicare-eligible members, including primary and specialty care coordination, prescription drug benefits, preventive services and access to a network of healthcare providers.

The company combines health-plan operations with proprietary technology intended to support personalized care.